Acadia Pharmaceuticals buy marge
Start price
29.03.17
/
50%
€32.33
Target price
29.09.17
€43.30
Performance (%)
7.06%
End price
29.09.17
€34.61
Summary
This prediction ended on 29.09.17 with a price of €34.61. The BUY prediction by marge finished with a performance of 7.06%. marge has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | 7.632% | 7.632% | 22.219% | 0.636% |
| iShares Core DAX® | 1.498% | -0.265% | 5.212% | 52.591% |
| iShares Nasdaq 100 | 1.854% | -0.066% | 37.788% | 90.508% |
| iShares Nikkei 225® | 0.411% | 4.084% | 60.701% | 76.928% |
| iShares S&P 500 | 1.479% | 0.783% | 26.350% | 66.805% |
Comments by marge for this prediction
In the thread Acadia Pharmaceuticals diskutieren
marge stimmt der Buy-Einschätzung von marge zu
marge stimmt am 28.09.2016 der Buy-Einschätzung von marge mit dem Kursziel 48$ zu.
Überschrift: Blockbuster-Potential zur Behandlung für Patienten mit Parkinson Psychose :
(Laufzeit überschritten)
Current prediction by marge for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.79
21.09.25
21.09.25
€39.00
21.09.26
21.09.26
9.24%
22:25
22:25
Stopped prediction by marge for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.05
09.03.21
09.03.21
€28.00
09.03.22
09.03.22
15.36%
10.03.22
10.03.22
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€40.76
13.12.19
13.12.19
€48.00
25.01.20
25.01.20
-12.41%
25.01.20
25.01.20
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€31.39
28.09.16
28.09.16
€43.30
28.03.17
28.03.17
2.43%
28.03.17
28.03.17
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.30
17.01.16
17.01.16
€38.79
18.07.16
18.07.16
33.46%
18.07.16
18.07.16
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€44.80
15.07.15
15.07.15
€52.32
15.01.16
15.01.16
-51.80%
15.01.16
15.01.16


